Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibodies Responses to SARS-CoV 2 Infection (COVID-19) in Hospitalized Patients. A Prospective Observational Study

NCT04520880 is registered in ClinicalTrials.gov with Imam Abdulrahman Bin Faisal University as lead sponsor.

NCT NCT04520880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04520880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibodies Responses to SARS-CoV 2 Infection (COVID-19) in Hospitalized Patients. A Prospective Observational Study
Lead sponsor
Imam Abdulrahman Bin Faisal University
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2020
Completion date
February 28, 2021
Enrollment
158 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hospitalized patients, laboratory-confirmed sars-cov 2 infection, severe acute respiratory syndrome coronavirus 2 (sars-cov 2 infection)